CN0042 - Reference Range Changes
CN0043 - ESR Sample Requirements
CN0045 - ESR Sample Viability
CN0046 - Changes to FBC Reports
CN0048 - CD69 Sample Stability
CN0049 - Lp-PLA2 (PLAC) Test
CN0050 - Rosalind Franklin Pathology Testing
CN0051 - Roche Elecsys AMH Assay
CN0052 - Serology Analysis
CN0053 - Test Information and Sample Requirement Update
CN0054 - Update to Serology Analysis
CN0055 - Flecainide Sample requirements
CN0060 - Change to Thrombotic Risk Profile (PROP)
CN0061 - NK Requests
CN0062 - Chain Of Custody Alcohol Level
CN0066 - Genetic Analysis for Cystic Fibrosis
CN0067 - AMH Analysis at MLP
CN0068 - Estradiol New Method and Reference Ranges
CN0070 - Private Cervical Cytology Smears and HPV triage
CN0071 - Confirmatory testing following DOA screening
CN0073 - Potassium reference ranges
CN0074 - Drug Interference affecting Patient results
CN0075 - MLP Mini Anti Mullerian Hormone (MAMH) Analysis at MLP
CN0080 - AMH Sample Stability
CN0081 - Drug Interference with Oestradiol Assay
CN0082 - Vitamin D Analysis
CN0088 - Change in EBV antibody test profile effective 09.01.2017
CN0089 - Quantiferon-TB Gold PLUS (QFT®-PLUS) Kit
CN0090 - Updated AMH Reference ranges and use
CN0091 - Launch of new Folate III assay
CN0092 - Quantiferon-TB Gold PLUS (QFT®-PLUS) KIT- UPDATE
CN0094 - Urinary Chromium and Nickel
CN0098 - Coagulation Screens
CN0099 - Culture and Sensitivity Testing
CN0100 - Change in Malaria Antibodies TAT
CN0101 - Microbiology Service Update
CN0103 - Updated AMH Test name
CN0104 - Fungal Mycology Update September 2017